Next Article in Journal
Acknowledgement to Reviewers of the Journal of Personalized Medicine in 2013
Next Article in Special Issue
DTC-and-Me: Patient, Provider, Proteins and Regulators
Previous Article in Journal / Special Issue
Barriers and Motivators for Referral of Patients with Suspected Lynch Syndrome to Cancer Genetic Services: A Qualitative Study
J. Pers. Med. 2014, 4(1), 35-49; doi:10.3390/jpm4010035

Physician Attitudes toward Adopting Genome-Guided Prescribing through Clinical Decision Support

Received: 11 December 2013 / Revised: 31 January 2014 / Accepted: 12 February 2014 / Published: 27 February 2014
(This article belongs to the Special Issue Bringing Personalized Medicine into Clinical Practice)
View Full-Text   |   Download PDF [664 KB, uploaded 27 February 2014]   |   Browse Figures


This study assessed physician attitudes toward adopting genome-guided prescribing through clinical decision support (CDS), prior to enlisting in the Clinical Implementation of Personalized Medicine through Electronic Health Records and Genomics pilot pharmacogenomics project (CLIPMERGE PGx). We developed a survey instrument that includes the Evidence Based Practice Attitude Scale, adapted to measure attitudes toward adopting genome-informed interventions (EBPAS-GII). The survey also includes items to measure physicians’ characteristics (awareness, experience, and perceived usefulness), attitudes about personal genome testing (PGT) services, and comfort using technology. We surveyed 101 General Internal Medicine physicians from the Icahn School of Medicine at Mount Sinai (ISMMS). The majority were residency program trainees (~88%). Prior to enlisting into CLIPMERGE PGx, most physicians were aware of and had used decision support aids. Few physicians, however, were aware of and had used genome-guided prescribing. The majority of physicians viewed decision support aids and genotype data as being useful for making prescribing decisions. Most physicians had not heard of, but were willing to use, PGT services and felt comfortable interpreting PGT results. Most physicians were comfortable with technology. Physicians who perceived genotype data to be useful in making prescribing decisions, had more positive attitudes toward adopting genome-guided prescribing through CDS. Our findings suggest that internal medicine physicians have a deficit in their familiarity and comfort interpreting and using genomic information. This has reinforced the importance of gathering feedback and guidance from our enrolled physicians when designing genome-guided CDS and the importance of prioritizing genomic medicine education at our institutions.
Keywords: clinical decision support; genomic medicine; clinician perceptions clinical decision support; genomic medicine; clinician perceptions
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Share & Cite This Article

Further Mendeley | CiteULike
Export to BibTeX |
MDPI and ACS Style

Overby, C.L.; Erwin, A.L.; Abul-Husn, N.S.; Ellis, S.B.; Scott, S.A.; Obeng, A.O.; Kannry, J.L.; Hripcsak, G.; Bottinger, E.P.; Gottesman, O. Physician Attitudes toward Adopting Genome-Guided Prescribing through Clinical Decision Support. J. Pers. Med. 2014, 4, 35-49.

View more citation formats

Related Articles

Article Metrics


Citing Articles

[Return to top]
J. Pers. Med. EISSN 2075-4426 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert